Sponsor Pipeline

FindCure Biosciences (ZhongShan) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1/2
1
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06499350 A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant… Advanced Malignant Solid Tumors Recruiting
Early Phase 1
NCT07468708 The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and… Healthy Adult Recruiting
NCT07459283 The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors Maligant Solid Tumor Not Yet Recruiting
NCT07542379 The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer Prostate Cancer Not Yet Recruiting
Disease Areas
Get alerts when FindCure Biosciences (ZhongShan) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free